AmSurg shares receive ‘buy’ rating: 5 notes

Analysts gave AmSurg shares a “buy” rating, according to Community Financial News.

Advertisement

Here are five notes:

1. Analysts have an average 12-month target price of $92.38 on AmSurg shares.  

2. On August 26, the shares increased 0.36 percent, reaching $77.38.  

3. The company has a 52-week low of $54.11 and a 52-week high of $87.42.

4. The 50-day moving average is $74.13 and the 200-day moving average is $74.41.

5. The market cap is $4.16 billion.

More articles on surgery centers:
10 largest ASC chains in the US
$10M medical campus opens with 8.5k-sq-ft ASC: 4 key notes
$8.9M Fort Meade Surgical Center opens: 3 key notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.